newsfilter
← Latest News
GlobeNewswire·

Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform

- Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical trial in 2026 - Updated electronics architecture